Bio-Matrix Files US and International Utility Patents on Its Stem Cell Extraction Medical Devices.SAN DIEGO -- Bio-Matrix Scientific Group, Inc. (Pink Sheets:BMXP BMXP Boston Metropolitan Exchange Point ), a biotechnology company focused on stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. cryogenics cryogenics: see low-temperature physics. cryogenics Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties. and disposable stem cell / tissue transfer instruments, (http://www.bmxgonline.com), announced today that it has filed US and International Utility Patent applications on its Stem Cell Extraction Medical Devices. These applications for international and domestic utility patents represent the Company's further protection of its intellectual property already covered under its provisional patents. The filing of these utility patent applications signify the Company's belief that designs currently in place are refined to the point of finalizing patent protection, both domestically and internationally. The purpose of filing of these applications is to perfect this protection. Brian Pockett, Managing Director and COO stated, "Our medical device sector is an area where both doctors and patients directly benefit from the innovation and technological progress of Bio-Matrix." Additionally, Bio-Matrix is rapidly moving forward on the completion of its new 15,000 sq ft state-of-the-art facility, located in San Diego which will house the Company's secure Cryogenic Stem Cell Bank, 3 Research labs, aseptic aseptic /asep·tic/ (-tik) free from infection or septic material. a·sep·tic adj. Of, relating to, or characterized by asepsis. cellular / tissue processing rooms, hematology, microbiology and flow cytometry flow cytometry (flōˑ sī·t  ˑ·m laboratories. This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMXP@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time. About Bio-Matrix Scientific Group Inc. Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are Cord Blood America (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CBAI CBAI The Community Bankers Association of Illinois CBAI Contract Bridge Association of Ireland (UK) ), StemCells Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :STEM) and Regeneration Technologies (OTCBB:RTIX). More information will be available shortly on the Company's website: www.BMXGonline.com. DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion